Motorola Mobility is being sued by a Google - funded
company over a patent infringement allegation into Android smartphones.
The Federal Court of Appeal has upheld $ 6.5 million in costs against Nova Chemical Corporation in a dispute with the Dow Chemical
Company over patent infringement.
Supposedly this is to address «patent trolls» which sue
companies over patents.
After spending much of 2015 battling with Chinese regulators and
companies over patent licenses, Qualcomm is hoping it has finally turned a corner.
Not exact matches
Sarepta Therapeutics, which won a pioneering Food and Drug Administration approval for its Duchenne muscular dystrophy drug last year, has settled a
patent dispute with rival BioMarin
over the «exon - skipping» technology at heart of the
companies» muscular dystrophy treatments.
The towing equipment
company announced it settled a four - year - old dispute with rival Hopkins
over patent rights to electronic brake controllers.
Now, the innovation pipelines are dry, the pharma
companies are peering (or falling)
over the
patent cliff.
Canada's Research In Motion (RIM) has lost a contract dispute
over the use of Nokia
patents in a case which could halt sales of its BlackBerry phones if it does not reach a deal to pay royalties to the Finnish
company.
The
companies had about 20 lawsuits pending
over uses of
patents in mobile phones, wireless connectivity, Internet video, and other technologies.
The combined
company could initially have annual sales of
over $ 65 billion, but there has been speculation that the merger could quickly be followed by a spinoff of some lower - margin businesses, including drugs that have lost
patent protection.
Partnering with Nant Capital and Dr. Patrick Soon - Shiong to accelerate the transformation from a legacy news
company to a technology and content
company, including gaining access to
over 100 machine vision and artificial intelligence technology
patents for news media applications.
The
company had already obtained
patents over the compounds, but asserted that it had evidence to support new uses for the compounds that merited further protection.
Two trade groups and about a dozen technology
companies signed a letter to the Trump administration late last week calling for the continuation of the U.S. Federal Trade Commission's lawsuit against Qualcomm
over patent licensing.
Looking at the portfolio, the
company's Innovative Health segment, which sells newer,
patent - protected drugs, contributed sales of $ 7.42 billion, representing growth of 5 % year
over year.
The venture capital database says it has selected from
over 2,000 private
companies in the AI field based on several criteria, which are: investor profile, tech innovation, team strength,
patent activity, mosaic score, funding history, valuation, and business model.
(A recent study by three Boston University researchers found that
patent trolls have cost publicly traded
companies an average of $ 83 - billion annually
over the past four years, more than a quarter of all U.S. industrial research and development spending during that period.)
Generally understood as a provision permitting
companies to test or experiment with
patented inventions prior to an FDA submission - such as a generic drug maker prior to submission of an ANDA - the provision's scope has expanded
over the years.
«Despite being just one of
over a dozen
companies who contributed to basic cellular standards, Qualcomm insists on charging Apple at least five times more in payments than all the other cellular
patent licensors we have agreements with combined,» Apple said in a statement.
With various
patents registered in their name and having worked with fortune 500
companies including venture capital funds, they bring in
over 150 + years of collective work experience.
As drug
patents begin to roll off and scrutiny around drug prices increased
over the summer, many pharmaceutical
company's struggled.
From a heritage family - owned
company, these glasses are handcrafted in
over 200 steps using the original handbuilt tooling equipment developed and
patented by the founders in 1972.
Driven by employee innovation, the
company has helped its employees to apply for
over 19,000
patents.
It certainly stands in stark contrast to the approach of tech
companies like Apple, which are suing their rivals all
over the world for infringing on
patents like the one it holds for rounded corners.
Like the American
company Nova Technology, which recently took out a blanket
patent (US
patent 4801613) which gives them rights to
over 10 million versions of their invention.
However, I used the time to get a job with a big German pharmaceutical
company, where I've been working in the
patent department, dealing mainly with biotechnology
patents and communicating with
patent offices and attorneys all
over the world.
Some
companies won't publish anything until the appropriate
patent has been issued, which can take well
over a year.
«
Over the past five years, our faculty has increasingly engaged in entrepreneurial and technology transfer activity — with significant increases in the number of U.S. and foreign
patents issued, technology inventions licensed and start - up
companies formed,» says UMSOM Dean E. Albert Reece, MD, PhD, MBA, vice president for medical affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor.
Uncertainties
over patent rights and safety regulations are deterring investors from putting money into bio-technology
companies.
It's being boycotted by Canadian health authorities and laboratories in the Netherlands, Belgium and Germany, challenged by the French government in a heated
patent dispute, and has provoked deep animosity in Britain as the
company negotiates with the National Health Service
over testing policy.
He is the author of
over 160 research papers, inventor of 24
patents and
patent applications, founder of 4 biotech
companies (Genom Analytik GmbH, Biopsytec GmbH and Epigenomics AG, Integragen SA).
ViaCyte Granted
Over 20
Patents in 2013 Further Establishing the
Company as a Leader in the Field of Regenerative Medicine
San Diego, California, October 29, 2013 — ViaCyte, Inc., a leading regenerative medicine
company focused on developing new approaches to treat major diseases through the application of a stem cell - derived cell therapy, announced today that the Company was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty f
company focused on developing new approaches to treat major diseases through the application of a stem cell - derived cell therapy, announced today that the
Company was granted over 20 patents worldwide in 2013 thus far, three U.S. and twenty f
Company was granted
over 20
patents worldwide in 2013 thus far, three U.S. and twenty foreign.
ProstaGene has
patented discoveries for cancer metastasis therapies and a highly predictive genetic test for prostate cancer outcome.The
company's prognostic test for prostate cancer showed dramatic improvement
over current technologies in three clinical studies.
Dr. Schork has published
over 500 peer - reviewed research articles, mentored
over 75 trainees, has been on 8
patents, has given
over 250 invited lectures, and has been involved in
over 15 different start - up
companies or commercial ventures in the biomedical space.
Thus, ViaCyte believes that the use of PEC - 01 cells has advantages
over the implantation of more fully differentiated cells such as insulin - producing beta cells; however, the
company continues to evaluate other approaches, as indicated by this
patent.
According to Forbe's research into intellectual property law, the language used in JDate's
patent was registered in 1999, and it is broad — broad enough (as mentioned earlier) to cover most dating websites and apps on the market today — so they could essentially claim IP infringement
over any other
company in the space.
The public
company has previously sued other rivals OkCupid, 2RedBeans and Zoosk
over this
patent.
I would say that Tesla's day's in the monopolistic sun are numbered - more than 120 electric car models have been promised to appear
over the next several years and Tesla has ZERO
patents to protect itself and has run out of govt subsidies in the U.S. - they are going to have to compete against
companies whose cars have a $ 7500 price advantage and will be unable to continue raping the consumer by selling zero emission credits.
The
company has been sued
over two
patents that have to do with electronic screens.
Interestingly, the timing of the new deal couldn't have come at a better time, what with a lot of
companies now engaged in
patent wars the world
over, and Apple itself featuring in a few of those.
Getting back to Apple and Motorola, those two
companies are suing each other
over more than 40 U.S.
patents.
BlackBerry on Monday issued a press release announcing that the
company has reached to an agreement with Typo
over its keyboard
patent infringement case.
All of this goes to show that no matter how heated legal disputes between
companies get — and Microsoft and B&N spent a good part of last year arguing
over Android - related
patents — business reasons can bring them into partnership just as quickly as they can drag them into court rooms.
The
company operates in more than 140 countries, has
over 85,000 employees, and has filed more than 53,000
patents.
The combined
company will have a portfolio of intellectual property that will include well
over 400
patents and applications.
The
company has been facing disputes from a number of its partners
over its
patents, licensing, and royalties.
Burst is a public
company which developed a
patent portfolio
over the past 19 years related to moving / streaming audio and video around a network, i.e., such as a LAN or the Internet.
Brian Feroldi:
Patent expirations on key drugs have wreaked havoc on many pharma
companies» financial statements
over the past few years, but few
companies have been hit as hard as Pfizer (NYSE: PFE).
Prior to joining Elanco, McGraw practiced as an in - house
patent counsel for Eli Lilly and
Company in Indianapolis for
over 14 years, where she gained experience in global
patent portfolio and exclusivity creation and managed the international
patent litigation associated with gemcitabine.
It seems that those cheeky boys and girls
over at Microsoft have gotten them in a spot of bother as Ohio - based
company Impulse Technology are claiming to have created the technology behind Kinect first, and that Kinect violates seven of their
patents for the technology, such as: «wide variety -LSB-...]